New England Research & Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$2.21M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.31M |
| 3 |
Advanced Micro Devices
AMD
|
+$1.22M |
| 4 |
Cirrus Logic
CRUS
|
+$982K |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$958K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.14M |
| 2 |
Intel
INTC
|
+$1.72M |
| 3 |
Ciena
CIEN
|
+$1.18M |
| 4 |
Eli Lilly
LLY
|
+$1.16M |
| 5 |
PepsiCo
PEP
|
+$844K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.84% |
| 2 | Technology | 20.82% |
| 3 | Consumer Staples | 15.19% |
| 4 | Industrials | 14.56% |
| 5 | Financials | 7.85% |
Similar funds
New England Research & Management's Q2 2020 Portfolio in Review
As of Q2 2020, New England Research & Management held 159 positions worth $140M, up 19% from $117M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
New England Research & Management deployed $4.69M of net new capital in Q2 2020, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Leidos: 22,479 shares worth $2.11M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Walt Disney, an estimated $2.14M trimmed.
- New England Research & Management's largest Q2 2020 buy was Leidos: 22,479 shares worth $2.11M.
- New England Research & Management added most to Waste Management in Q2 2020, an estimated $947K increase.
- New England Research & Management's biggest Q2 2020 reduction was Walt Disney, cutting an estimated $2.14M.
- New England Research & Management fully exited Ciena in Q2 2020, selling an estimated $1.18M.
- New England Research & Management's ten largest holdings make up 25% of its $140M portfolio in Q2 2020.
- New England Research & Management opened 26 new positions and closed 18 in Q2 2020.
- New England Research & Management's portfolio value rose 19% quarter-over-quarter to $140M.
Based on New England Research & Management's 13F filing for Q2 2020, filed 15 Jul 2020.